LiVeritas Biosciences Introduces the LiLii™ Platform – An Integrated Laboratory Ecosystem Powered by AI

Groundbreaking Offering Unifies Lab Best Practices, Analytical Operations, Project Management and Communications for Drug Developers SAN FRANCISCO, July 19, 2023 /PRNewswire/ — LiVeritas Biosciences, Inc. today announced beta testing of their LiLii™ platform, a next-generation, fully…

Click here to view original post

Advertisement — Advertise with Biotech Networks